Treatment for patients with unilateral aldosteronism: surgical or medical treatment

Affiliations

¹ Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. umakoshi.hironobu.189@m.kyushu-u.ac.jp.

Editorial

Hiroki Kaneko et al. Hypertens Res. 2025.

. 2025 Aug 22.

doi: 10.1038/s41440-025-02340-7. Online ahead of print.

¹ Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. umakoshi.hironobu.189@m.kyushu-u.ac.jp.

No abstract available

Keywords: Adrenalectomy; Aldosterone; Mineralocorticoid receptor antagonists; Primary aldosteronism.

Conflict of interest statement

Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.

A systematic review to compare adrenalectomy and mineralocorticoid receptor antagonists in patients with unilateral primary aldosteronism.
Yoshida Y, Kinouchi K, Nagai S, Sakima A, Takami Y, Arima H, Miyashita K, Mukoyama M. Yoshida Y, et al. Hypertens Res. 2025 Sep;48(9):2368-2375. doi: 10.1038/s41440-025-02273-1. Epub 2025 Jul 4. Hypertens Res. 2025. PMID: 40615697 Review.

1. Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41–50. - PubMed
1. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916. - PubMed
1. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481. - PubMed
1. Yoshida Y, Kinouchi K, Nagai S, Sakima A, Takami Y, Arima H, et al. A systematic review to compare adrenalectomy and mineralocorticoid receptor antagonists in patients with unilateral primary aldosteronism. Hypertens Res. 2025. Online ahead of print. https://doi.org/10.1038/s41440-025-02273-1 .
1. Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99. - PubMed - PMC